{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:00:55Z","timestamp":1740135655730,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["(NIH\/NCATS UL1 TR000445)."],"award-info":[{"award-number":["(NIH\/NCATS UL1 TR000445)."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Impedimed","award":["Industry Sponsor"],"award-info":[{"award-number":["Industry Sponsor"]}]},{"name":"medi","award":["Industry Sponsor"],"award-info":[{"award-number":["Industry Sponsor"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1245\/s10434-019-07804-y","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T18:05:36Z","timestamp":1568311536000},"page":"865-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to Letter to the Editor Regarding \u201cA Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis\u201d"],"prefix":"10.1245","volume":"26","author":[{"given":"Sheila","family":"Ridner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"7804_CR1","volume-title":"Diagnosis and treatment of secondary lymphedema","author":"M Oremus","year":"2010","unstructured":"Oremus M, et al. Diagnosis and treatment of secondary lymphedema. Hamilton: McMaster University Evidence-based Practice Center; 2010."},{"issue":"1","key":"7804_CR2","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish BH, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2\u201311.","journal-title":"Lymphology"},{"issue":"1","key":"7804_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","volume":"73","author":"RL Wasserstein","year":"2019","unstructured":"Wasserstein RL, et al. Moving to a world beyond \u201cp\u2009<\u20090.05\u201d. Am Stat. 2019;73(1):1\u201319.","journal-title":"Am Stat"},{"issue":"11","key":"7804_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jama.2016.2152","volume":"315","author":"DN Kyriacou","year":"2016","unstructured":"Kyriacou DN. The enduring evolution of the P value editorial. JAMA. 2016;315(11):1113\u20135.","journal-title":"JAMA"},{"issue":"10","key":"7804_CR5","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1245\/s10434-018-6601-8","volume":"25","author":"LJ Kilgore","year":"2018","unstructured":"Kilgore LJ, et al. Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol. 2018;25(10):2918\u201352.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7804_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/lrb.2014.0035","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12(4):289\u201394.","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"7804_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.20001","volume":"59","author":"BD Lawenda","year":"2009","unstructured":"Lawenda BD, et al. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59(1):8\u201324.","journal-title":"CA Cancer J Clin"},{"key":"7804_CR8","volume-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) for breast cancer V.2.2017","author":"NCCN","year":"2017","unstructured":"NCCN. NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) for breast cancer V.2.2017. Fort Washington: NCCN; 2017."},{"key":"7804_CR9","volume-title":"Lymphoedema: A guide for clinical services","author":"ACI","year":"2018","unstructured":"ACI. Lymphoedema: a guide for clinical services. Chatswood: NSW Agency for Clinical Innovation; 2018."},{"issue":"12","key":"7804_CR10","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"L Stout Gergich","year":"2008","unstructured":"Stout Gergich L, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809\u201319.","journal-title":"Cancer"},{"issue":"2","key":"7804_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clbc.2012.01.004","volume":"12","author":"F Vicini","year":"2012","unstructured":"Vicini F, et al. Bioelectrical impedance for detecting and monitoring patients for the development of upper limb lymphedema in the clinic. Clin Breast Cancer. 2012;12(2):133\u20137.","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"7804_CR12","first-page":"184","volume":"46","author":"C Shah","year":"2013","unstructured":"Shah C, et al. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema. Lymphology. 2013;46(4):184\u201392.","journal-title":"Lymphology"},{"issue":"1","key":"7804_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1188\/17.CJON.21-25","volume":"21","author":"K Reichart","year":"2017","unstructured":"Reichart K. Lymphedema: improving screening and treatment among at-risk breast cancer survivors. Clin J Oncol Nurs. 2017;21(1):21\u20135.","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"7804_CR14","first-page":"17","volume":"100","author":"L Barney","year":"2015","unstructured":"Barney L and Savarise MT. 2015 CPT coding changes will have mixed effects on payment for general surgeons. Bull Am Coll Surg. 2015;100(1):17\u201326.","journal-title":"Bull Am Coll Surg"},{"issue":"6","key":"7804_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/cncr.31873","volume":"125","author":"LA Koelmeyer","year":"2018","unstructured":"Koelmeyer LA, et al. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer. 2018;125(6):854\u201362.","journal-title":"Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07804-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:05:35Z","timestamp":1599779135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07804-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":15,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7804"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07804-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chirag Shah is scientific consultant for ImpediMed Limited. Frank Vicini is scientific consultant and chief medical officer for ImpediMed Limited.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}